1.0(top 50%)
impact factor
40(top 100%)
papers
532(top 50%)
citations
11(top 50%)
h-index
2.2(top 20%)
extended IF
282
all documents
546
doc citations
17(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201940
2Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201923
3Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201918
4AMRcloud: a new paradigm in monitoring of antibiotic resistanceKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201916
5Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201916
6Antimicrobal resistance of nosocomial carbapenemase-producing Enterobacterales in Russia: results of surveillance, 2014-2016Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201814
7Antimicrobial resistance of clinical Streptococcus pneumoniae isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia201911
8Comparative review of the modern methods for carbapenemases detectionKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20199
9Application of AMRmap: «from the general to the specific» approach by the example of Klebsiella pneumoniaeKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20197
10Antibiotics and community-acquired lower respiratory tract infections. To whom? Which one?Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20195
11New probiotic strain Streptococcus salivarius K12 in clinical practiceKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20195
12Antimicrobial resistance of Gram-negative pathogens of nosocomial pneumonia in intensive care unit patientsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20195
13Characterization of genetic diversity of the Klebsiella pneumoniae strains in a Moscow tertiary care center using next-generation sequencingKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20194
14Detection of acquired carbapenemase genes among Acinetobacter baumannii isolated from blood culture in patients with hematological malignanciesKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20194
15Gastrointestinal adverse drug reactions and antibiotic-associated diarrhea during antibiotic therapy in outpatient practice: prevention and treatmentKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20194
16Comparison of the qSOFA and NEWS scores and the SIRS criteria in predicting outcomes in emergency department patients with and without infection: results from a prospective observational studyKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20193
17Acute liver failure in adultsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20193
18The evidence base and practical approaches to probiotic use in clinical practice: a focus on Lactobacillus rhamnosus GG and Bifidobacterium lactis Вb-12Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20193
19Dalbavancin in the treatment of skin and soft tissue infectionsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20182
20Pharmacoepidemiology of peptic ulcer in Smolensk: 15 years laterKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20192
21The results of identification of bacteria from positive blood cultures using MALDI-TOF mass spectrometryKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20182
22Genotypes and metallo-beta-lactamases carriage in carbapenem-resistant Pseudomonas aeruginosa isolated from children in MoscowKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20182
23Burden of resistant infections caused by S. aureus, E. coli, K. pneumoniae in Russian FederationKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20182
24Review of the Guidelines of the Spanish Society of Chemotherapy on antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosaKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20181
25Ceftolozane/tazobactam – the «new player» in a battle against multiresistant pathogensKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20181
26Healthcare-associated meningitis and ventriculitis: diagnosis, treatment and prophylaxisKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20181
27Species diversity and methicillin resistance in Staphylococcus spp. in nosocomial infectionsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20191
28Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infectionsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20191
29Integrated analysis of antibiotic consumption in the hospital segment of Saint-Petersburg in 2014–2018Kliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20191
30Review of the ASCO and IDSA clinical practice guidelines on antimicrobial prophylaxis for adult patients with cancer-related immunosupressionKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20191
31Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adultsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20191
32Molecular characterization of extended-spectrum beta-lactamase-producing Enterobacterales isolates collected from blood culture in patients with hematological malignanciesKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20180
33Level of physicians’ awareness of epidemiology, outcomes, prevention and treatment of chronic hepatitis B and CKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20180
34Pseudomonas aeruginosa in the etiology of infections in hospitalized patientsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20180
35Safety and efficacy of nemonoxacin versus levofloxacin in the treatment of community-acquired pneumonia: results of phase III, multicenter, randomized, double-blind, active-controlled, non-inferiority trialKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20180
36Antimicrobial susceptibility of Streptococcus pneumoniae in KazakhstanKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20190
37Experimental evidence of antimicrobial effect of silver-coated silicon urological cathetersKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20190
38Cefotaxime/sulbactam: clinical and pharmacological characteristicsKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20190
39Clinical case of difficult differential diagnosis between liver cirrhosis and hepatocellular carcinoma associated with HCV infection in a patient with prolonged alcohol exposureKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20190
40Mucormycosis in children with hematological malignancies: results of a single-center studyKliniceskaa Mikrobiologia I Antimikrobnaa Himioterapia20190